Greenleaf Trust’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$581K Sell
36,589
-381
-1% -$5.91K 0.01% 478
2026
Q1
$499K Buy
36,970
+1,895
+5% +$26.5K ﹤0.01% 491
2025
Q4
$437K Buy
35,075
+1,124
+3% +$12.1K ﹤0.01% 543
2025
Q3
$336K Sell
33,951
-1,922
-5% -$18.7K ﹤0.01% 606
2025
Q2
$320K Sell
35,873
-793
-2% -$6.71K ﹤0.01% 611
2025
Q1
$319K Buy
36,666
+5,454
+17% +$57.3K ﹤0.01% 624
2024
Q4
$389K Sell
31,212
-651
-2% -$8K ﹤0.01% 573
2024
Q3
$370K Buy
31,863
+1,485
+5% +$17.1K ﹤0.01% 591
2024
Q2
$323K Buy
30,378
+404
+1% +$4.46K ﹤0.01% 595
2024
Q1
$358K Buy
29,974
+239
+0.8% +$2.88K ﹤0.01% 552
2023
Q4
$322K Sell
29,735
-13,454
-31% -$129K ﹤0.01% 577
2023
Q3
$426K Buy
43,189
+711
+2% +$7.4K ﹤0.01% 482
2023
Q2
$424K Sell
42,478
-232
-0.5% -$2.22K ﹤0.01% 489
2023
Q1
$411K Buy
42,710
+4,659
+12% +$51.7K ﹤0.01% 509
2022
Q4
$424K Buy
38,051
+8,958
+31% +$93.6K 0.01% 490
2022
Q3
$248K Buy
29,093
+282
+1% +$2.78K ﹤0.01% 609
2022
Q2
$302K Sell
28,811
-205
-0.7% -$2.25K ﹤0.01% 551
2022
Q1
$316K Buy
29,016
+753
+3% +$9.92K ﹤0.01% 574
2021
Q4
$382K Sell
28,263
-1,516
-5% -$20.2K ﹤0.01% 520
2021
Q3
$404K Sell
29,779
-2,808
-9% -$39.8K ﹤0.01% 470
2021
Q2
$466K Sell
32,587
-4,507
-12% -$65.2K 0.01% 414
2021
Q1
$518K Sell
37,094
-9,906
-21% -$161K 0.01% 366
2020
Q4
$881K Buy
47,000
+32,451
+223% +$529K 0.01% 201
2020
Q3
$216K Buy
14,549
+3,373
+30% +$53.9K ﹤0.01% 502
2020
Q2
$180K Buy
+11,176
New +$181K ﹤0.01% 520

Other funds holding VTRS

Greenleaf Trust's VTRS Position: Q2 2026 in Review

Greenleaf Trust reduced its Viatris (VTRS) stake by 1% in Q2 2026, selling an estimated $5.91K and leaving 36,589 shares worth $581K. The position accounts for 0.01% of the portfolio, ranked #478.

Greenleaf Trust first reported a position in VTRS in Q2 2020 and has held it in 25 quarters since. The position peaked at $881K in Q4 2020. 189 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Greenleaf Trust held 36,589 shares of Viatris worth $581K as of Q2 2026.
  • Greenleaf Trust sold 381 Viatris shares in Q2 2026, an estimated $5.91K.
  • Viatris made up 0.01% of Greenleaf Trust's portfolio in Q2 2026, its #478 holding.
  • Greenleaf Trust first reported a position in Viatris in Q2 2020 and has held it in 25 quarters since.
  • Greenleaf Trust's Viatris position peaked at $881K in Q4 2020.
  • 189 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.